
Drug Development
Brexpiprazole as a New Serotonin–Dopamine Receptor Modulator: Considering the Clinical Relevance for Metabolic Parameters and Prolactin Levels
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD
by Mark E. Whitlock, PhD; Philip W. Woodward, MPhil; and
Dear Editor: Social media platforms are increasingly used to disseminate
by Leslie Citrome, MD, MPH; Stephanie S. O’Malley, PhD; David
by Ashutosh Kumar, MD; Vikas Pareek, PhD; Muneeb A. Faiq,
by Laetitia Pouzol, MSc, PharmD; Luca Piali, PhD; Claude CA
by Niro Kasahara, MD; Mateus L. Matuoka, MD; Katia S.
by Ryan Bart, DO; Waguih William IsHak, MD, FAPA; Shaina
by Evgenia Ivanova, PhD; Anzalee Khan, PhD; Lora Liharska, MS;
By Clare Brennan, DPT, MSPH; Hannah Whillis, MS; Choy Man,